Notch and NF-κB signaling pathways in the biology of classical Hodgkin lymphoma

Tools

Item Type:	Review
Title:	Notch and NF-κB signaling pathways in the biology of classical Hodgkin lymphoma
Creators Name:	Schwarzer, R. and Jundt, F.
Abstract:	Classical Hodgkin lymphoma (cHL) is now recognized as a B-cell-derived lymphoma which is characterized by only about 1% malignant pathognomonic Hodgkin and Reed-Sternberg (HRS) cells and an abundant infiltrate of reactive bystander cells. HRS cells are unique with respect to their lost B-cell-specific gene expression pattern and recurrent genetic lesions. Aberrant activity of Notch signaling, a highly conserved developmental pathway, acts as a negative regulator of the B cell program in HRS cells and thereby contributes to their reprogramming. Another striking feature and the major pathogenetic mechanism in HRS cells is constitutive NF-κB activation. A number of aberrations that contribute to canonical NF-κB activity in HRS cells have been described such as genetic lesions, deregulated receptor signaling and Epstein-Barr virus (EBV) infection. The importance of Notch and NF-κB signaling for cHL pathogenesis, their potential cross-talk and implications for future therapeutic applications are being discussed.
Keywords:	Notch, NF-κB, Hodgkin Lymphoma, B Cell Lymphoma, Hodgkin/Reed-Sternberg Cells, Gene Transcription, Mutations, Immunoprecipitation, Inflammatory Cells, Cytokine, Helix-Loop-Helix Proteins, Epstein-Barr Virus, Multiple Myeloma, B-Chronic Lymphocytic Leukemia, Tumor Suppressor Gene, Animals
Source:	Current Molecular Medicine
ISSN:	1566-5240
Publisher:	Bentham
Volume:	11
Number:	3
Page Range:	236-245
Date:	April 2011
Official Publication:	https://doi.org/10.2174/156652411795243423
PubMed:	View item in PubMed

Repository Staff Only: item control page